UBS lowered the firm’s price target on Axon (AXON) to $440 from $570 and keeps a Neutral rating on the shares. The strong quarter and guidance are unlikely to offset concerns about AI and free cash flow, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON:
- Why Is Invesco QQQ Trust ETF (QQQ) Inching Higher, 5/7/2026?
- Axon price target lowered to $700 from $825 at Citizens
- Axon Maintained at Buy as Strong Growth Outlook Supports Unchanged $600 Price Target
- Axon Enterprise options imply 12.5% move in share price post-earnings
- Axon reports Q1 EPS $1.61, consensus $1.60